Isturisa is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Recordati Rare Diseases, Inc.. The primary component is Osilodrostat Phosphate.
Product ID | 55292-322_06e491a0-5048-424a-9fa3-5109679d7908 |
NDC | 55292-322 |
Product Type | Human Prescription Drug |
Proprietary Name | Isturisa |
Generic Name | Osilodrostat |
Dosage Form | Tablet, Coated |
Route of Administration | ORAL |
Marketing Start Date | 2020-03-31 |
Marketing Category | NDA / NDA |
Application Number | NDA212801 |
Labeler Name | Recordati Rare Diseases, Inc. |
Substance Name | OSILODROSTAT PHOSPHATE |
Active Ingredient Strength | 10 mg/1 |
Pharm Classes | Cortisol Synthesis Inhibitor [EPC], Cytochrome P450 11B1 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Cytochrome P450 3A5 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2024-12-31 |
Marketing Start Date | 2020-03-31 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212801 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-03-31 |
Marketing Category | NDA |
Application Number | NDA212801 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2020-03-31 |
Ingredient | Strength |
---|---|
OSILODROSTAT PHOSPHATE | 10 mg/1 |
SPL SET ID: | f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
55292-320 | Isturisa | Osilodrostat |
55292-321 | Isturisa | Osilodrostat |
55292-322 | Isturisa | Osilodrostat |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ISTURISA 79187535 5061675 Live/Registered |
NOVARTIS AG 2016-03-30 |